Exogenous Soluble VEGF Receptor-1 (sFlt-1) Regulates Th1/Th2 Cytokine Production from Normal Placental Explants via Intracellular Calcium

REFERENCES

• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308:1592–1594.
   PubMed Web of Science ®Google Scholar
• Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 122:33–39.
   PubMed Web of Science ®Google Scholar
• Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90:4895–4903.
   PubMed Web of Science ®Google Scholar
• Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111:649–658.
   PubMed Web of Science ®Google Scholar
• Polliotti BM, Fry AG, Saller DN, Mooney RA, Cox C, Miller RK. Second-trimester maternal serum placental growth factor and vascular endothelial growth factor for predicting severe, early-onset preeclampsia. Obstet Gynecol 2003; 101:1266–1274.
   PubMed Web of Science ®Google Scholar
• Makris A, Thornton C, Thompson J, Thomson S, Martin R, Ogle R, Waugh R, McKenzie P, Kirwan P, Hennessy A. Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1. Kidney Int 2007; 71:977–984.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review. Placenta 2003; 24 Suppl A:S21–27.
   PubMed Web of Science ®Google Scholar
• Wang Y, Walsh SW. TNF alpha concentrations and mRNA expression are increased in preeclamptic placentas. J Reprod Immunol 1996; 32:157–169.
   PubMed Web of Science ®Google Scholar
• Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 1999; 163:3491–3495.
   PubMed Web of Science ®Google Scholar
• Orange S, Rasko JE, Thompson JF, Vaughan J, Olive E, Pedler M, Horvath JS, Hennessy A. Interleukin-10 regulates arterial pressure in early primate pregnancy. Cytokine 2005; 29:176–185.
   PubMed Web of Science ®Google Scholar
• Saito S, Sakai M. Th1/Th2 balance in preeclampsia. J Reprod Immunol 2003; 59:161–173.
   PubMed Web of Science ®Google Scholar
• Turner MA, Shaikh SA, Greenwood SL. Secretion of interleukin-1beta and interleukin-6 by fragments of term human placental villi: signalling pathways and effects of tumour necrosis factor alpha and mode of delivery. Placenta 2002; 23:467–474.
   PubMed Web of Science ®Google Scholar
• Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997; 82:1582–1588.
   PubMed Web of Science ®Google Scholar
• Xu B, Makris A, Thornton C, Ogle R, Horvath JS, Hennessy A. Antihypertensive drugs clonidine, diazoxide, hydralazine and furosemide regulate the production of cytokines by placentas and peripheral blood mononuclear cells in normal pregnancy. J Hypertens 2006; 24:915–922.
   PubMed Web of Science ®Google Scholar
• Macfarlane SR, Sloss CM, Cameron P, Kanke T, McKenzie RC, Plevin R. The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes. Br J Pharmacol 2005; 145:535–544.
   PubMed Web of Science ®Google Scholar
• Di Santo S, Malek A, Sager R, Andres AC, Schneider H. Trophoblast viability in perfused term placental tissue and explant cultures limited to 7-24 hours. Placenta 2003; 24:882–894.
   PubMed Web of Science ®Google Scholar
• Moore KW, de Waal Malefyt R, Coffman RL, O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001; 19:683–765.
   PubMed Web of Science ®Google Scholar
• Saito S. Cytokine network at the feto-maternal interface. J Reprod Immunol 2000; 47:87–103.
   PubMed Web of Science ®Google Scholar
• Naldini A, Pucci A, Bernini C, Carraro F. Regulation of angiogenesis by Th1- and Th2-type cytokines. Curr Pharm Des 2003; 9:511–519.
   PubMed Web of Science ®Google Scholar
• Hunt JS, Chen HL, Miller L. Tumor necrosis factors: pivotal components of pregnancy?. Biol Reprod 1996; 54:554–562.
   PubMed Web of Science ®Google Scholar
• Beckmann I, Efraim SB, Vervoort M, Visser W, Wallenburg HC. Tumor necrosis factor-alpha in whole blood cultures of preeclamptic patients and healthy pregnant and nonpregnant women. Hypertens Pregnancy 2004; 23:319–329.
   PubMed Web of Science ®Google Scholar
• Conrad KP, Miles TM, Benyo DF. Circulating levels of immunoreactive cytokines in women with preeclampsia. Am J Reprod Immunol 1998; 40:102–111.
   PubMed Web of Science ®Google Scholar
• Benyo DF, Smarason A, Redman CW, Sims C, Conrad KP. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001; 86:2505–2512.
   PubMed Web of Science ®Google Scholar
• Hung TH, Charnock-Jones DS, Skepper JN, Burton GJ. Secretion of tumor necrosis factor-alpha from human placental tissues induced by hypoxia-reoxygenation causes endothelial cell activation in vitro: a potential mediator of the inflammatory response in preeclampsia. Am J Pathol 2004; 164:1049–1061.
   PubMed Web of Science ®Google Scholar
• Ahmad S, Ahmed A. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia. Circ Res 2004; 95:884–891.
   PubMed Web of Science ®Google Scholar
• Belkacemi L, Bedard I, Simoneau L, Lafond J. Calcium channels, transporters and exchangers in placenta: a review. Cell Calcium 2005; 37:1–8.
   PubMed Web of Science ®Google Scholar
• Rafiq K, Charitidou L, Bullens DM, Kasran A, Lorre K, Ceuppens J, van Gool SW. Regulation of the IL-10 production by human T cells. Scand J Immunol 2001; 53:139–147.
   PubMed Web of Science ®Google Scholar
• Crabtree GR. Calcium, calcineurin, and the control of transcription. J Biol Chem 2001; 276:2313–2316.
   PubMed Web of Science ®Google Scholar
• Mendez-Samperio P, Trejo A, Miranda E. Activation of ERK1/2 and TNF-alpha production are mediated by calcium/calmodulin, and PKA signaling pathways during Mycobacterium bovis infection. J Infect 2006; 52:147–153.
   PubMed Web of Science ®Google Scholar
• Krysiak O, Bretschneider A, Zhong E, Webb J, Hopp H, Verlohren S, Fuhr N, Lanowska M, Nonnenmacher A, Vetter R, Jankowski J, Paul M, Schonfelder G. Soluble vascular endothelial growth factor receptor-1 (sFLT-1) mediates downregulation of FLT-1 and prevents activated neutrophils from women with preeclampsia from additional migration by VEGF. Circ Res 2005; 97:1253–1261.
   PubMed Web of Science ®Google Scholar
• Mor F, Quintana FJ, Cohen IR. Angiogenesis-inflammation cross-talk: vascular endothelial growth factor is secreted by activated T cells and induces Th1 polarization. J Immunol 2004; 172:4618–4623.
   PubMed Web of Science ®Google Scholar
• Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, Liao F, Nagy JA, Hooper A, Priller J, De Klerck B, Compernolle V, Daci E, Bohlen P, Dewerchin M, Herbert JM, Fava R, Matthys P, Carmeliet G, Collen D, Dvorak HF, Hicklin DJ, Carmeliet P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 2002; 8:831–840.
   PubMed Web of Science ®Google Scholar
• Lingen MW. Role of leukocytes and endothelial cells in the development of angiogenesis in inflammation and wound healing. Arch Pathol Lab Med 2001; 125:67–71.
   PubMed Web of Science ®Google Scholar